NO20051688D0 - Farmasoytiske blandinger som har en modifisert baerer - Google Patents

Farmasoytiske blandinger som har en modifisert baerer

Info

Publication number
NO20051688D0
NO20051688D0 NO20051688A NO20051688A NO20051688D0 NO 20051688 D0 NO20051688 D0 NO 20051688D0 NO 20051688 A NO20051688 A NO 20051688A NO 20051688 A NO20051688 A NO 20051688A NO 20051688 D0 NO20051688 D0 NO 20051688D0
Authority
NO
Norway
Prior art keywords
pharmaceutical compositions
modified carrier
carrier
modified
pharmaceutical
Prior art date
Application number
NO20051688A
Other languages
English (en)
Other versions
NO20051688L (no
Inventor
Susan Marie Machkovech
Niki Ann Waldron
Nancy Jean Britten
Dannette Marie Shaw
Ondrej Hendl
Alanta Lea Lary
Thomas Joseph Yellig
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32326579&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20051688(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of NO20051688D0 publication Critical patent/NO20051688D0/no
Publication of NO20051688L publication Critical patent/NO20051688L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
NO20051688A 2002-11-19 2005-04-05 Farmasoytiske blandinger som har en modifisert baerer NO20051688L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42768002P 2002-11-19 2002-11-19
PCT/IB2003/005234 WO2004045646A1 (en) 2002-11-19 2003-11-17 Pharmaceutical compositions having a modified vehicle

Publications (2)

Publication Number Publication Date
NO20051688D0 true NO20051688D0 (no) 2005-04-05
NO20051688L NO20051688L (no) 2005-08-02

Family

ID=32326579

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051688A NO20051688L (no) 2002-11-19 2005-04-05 Farmasoytiske blandinger som har en modifisert baerer

Country Status (18)

Country Link
US (1) US7659061B2 (no)
EP (1) EP1569693B1 (no)
JP (1) JP4656945B2 (no)
KR (1) KR20050085037A (no)
CN (2) CN103272243A (no)
AR (1) AR042193A1 (no)
AU (1) AU2003276594B2 (no)
BR (1) BR0316310A (no)
CA (1) CA2502025C (no)
IL (1) IL168183A (no)
MX (1) MXPA05005319A (no)
NO (1) NO20051688L (no)
NZ (1) NZ539923A (no)
PL (1) PL377740A1 (no)
RU (1) RU2401127C2 (no)
TW (1) TWI267379B (no)
WO (1) WO2004045646A1 (no)
ZA (1) ZA200503040B (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2303026B1 (en) 2008-06-17 2020-09-09 Brigham Young University Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
CN104039369B (zh) 2011-07-20 2017-06-16 布莱阿姆青年大学 疏水性塞拉集宁化合物和包含该化合物的装置
CN104080459B (zh) 2011-09-13 2018-07-03 布莱阿姆青年大学 用于治疗骨疾病和断骨的组合物
US9603859B2 (en) 2011-09-13 2017-03-28 Brigham Young University Methods and products for increasing the rate of healing of tissue wounds
US9694019B2 (en) 2011-09-13 2017-07-04 Brigham Young University Compositions and methods for treating bone diseases and broken bones
EP2760454B1 (en) 2011-09-13 2018-08-29 Brigham Young University Products for healing of tissue wounds
CA2859325A1 (en) 2011-12-21 2013-07-25 Brigham Young University Oral care compositions
US9533063B1 (en) 2012-03-01 2017-01-03 Brigham Young University Aerosols incorporating ceragenin compounds and methods of use thereof
US10039285B2 (en) 2012-05-02 2018-08-07 Brigham Young University Ceragenin particulate materials and methods for making same
BR112015008804A2 (pt) 2012-10-17 2017-07-04 Univ Brigham Young tratamento e prevenção de mastite
WO2014107740A2 (en) 2013-01-07 2014-07-10 Brigham Young University Methods for reducing cellular proliferation and treating certain diseases
US10568893B2 (en) 2013-03-15 2020-02-25 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
BR112015023747B1 (pt) 2013-03-15 2023-04-18 Brigham Young University Uso de um composto antimicrobiano catiônico esteroide (csa) para a preparação de uma composição para tratar, reduzir, ou prevenir inflamação aguda ou crônica e/ou dor aguda ou crônica associada com uma doença ou um sintoma de doença
US11524015B2 (en) 2013-03-15 2022-12-13 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US9387215B2 (en) 2013-04-22 2016-07-12 Brigham Young University Animal feed including cationic cholesterol additive and related methods
US11690855B2 (en) 2013-10-17 2023-07-04 Brigham Young University Methods for treating lung infections and inflammation
US20150203527A1 (en) 2014-01-23 2015-07-23 Brigham Young University Cationic steroidal antimicrobials
CA2844321C (en) 2014-02-27 2021-03-16 Brigham Young University Cationic steroidal antimicrobial compounds
US10220045B2 (en) 2014-03-13 2019-03-05 Brigham Young University Compositions and methods for forming stabilized compositions with reduced CSA agglomeration
US9867836B2 (en) 2014-03-13 2018-01-16 Brigham Young University Lavage and/or infusion using CSA compounds for increasing fertility in a mammal
US9931350B2 (en) 2014-03-14 2018-04-03 Brigham Young University Anti-infective and osteogenic compositions and methods of use
CN106456704A (zh) 2014-04-16 2017-02-22 Veyx-药物有限公司 兽药组合物和其应用
US9686966B2 (en) 2014-04-30 2017-06-27 Brigham Young University Methods and apparatus for cleaning or disinfecting a water delivery system
US10238665B2 (en) 2014-06-26 2019-03-26 Brigham Young University Methods for treating fungal infections
US10441595B2 (en) 2014-06-26 2019-10-15 Brigham Young University Methods for treating fungal infections
US10227376B2 (en) 2014-08-22 2019-03-12 Brigham Young University Radiolabeled cationic steroid antimicrobials and diagnostic methods
US10155788B2 (en) 2014-10-07 2018-12-18 Brigham Young University Cationic steroidal antimicrobial prodrug compositions and uses thereof
US10370403B2 (en) 2015-04-22 2019-08-06 Brigham Young University Methods for the synthesis of ceragenins
US9527883B2 (en) 2015-04-22 2016-12-27 Brigham Young University Methods for the synthesis of ceragenins
US9434759B1 (en) 2015-05-18 2016-09-06 Brigham Young University Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds
US10226550B2 (en) 2016-03-11 2019-03-12 Brigham Young University Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
US10959433B2 (en) 2017-03-21 2021-03-30 Brigham Young University Use of cationic steroidal antimicrobials for sporicidal activity

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US110561A (en) * 1870-12-27 Improvement in children s carriages
US4297353A (en) 1980-08-04 1981-10-27 Sandoz, Inc. Non-irritating injectable dosage forms
KR890002631B1 (ko) * 1984-10-04 1989-07-21 몬산토 캄파니 생물학적으로 활성인 소마토트로핀을 지속적으로 유리하는 조성물
US5019395A (en) 1988-03-08 1991-05-28 Warner-Lambert Company Compositions with enhanced penetration
JP2856444B2 (ja) * 1989-07-28 1999-02-10 呉羽化学工業株式会社 ビタミンｄ▲下３▼代謝産物製剤
JP3078859B2 (ja) 1990-02-23 2000-08-21 武田薬品工業株式会社 安定な放出制御性製剤用コーティング剤
FR2692480B1 (fr) 1992-06-22 1995-12-08 Technico Flor Sa Nouvelles compositions cosmetiques ou alimentaires renfermant du copaiba.
CN1055090C (zh) * 1993-03-12 2000-08-02 法玛西雅厄普约翰美国公司 结晶性头孢噻夫游离酸
DE4340879A1 (de) 1993-12-01 1995-06-08 Horst P O Dr Wolf Arzneimittel zur Behandlung der Herzinsuffizienz
ATE252894T1 (de) 1995-01-05 2003-11-15 Univ Michigan Oberflächen-modifizierte nanopartikel und verfahren für ihre herstellung und verwendung
EP0914126B1 (en) 1996-06-27 2003-08-27 Janssen Pharmaceutica N.V. Sustained release sufentanil compositions
US5736151A (en) * 1996-12-09 1998-04-07 Pharmacia & Upjohn Company Antibiotic oil suspensions
US6074657A (en) 1997-03-20 2000-06-13 Pharmacia & Upjohn Company Administration of an injectable antibiotic in the ear of an animal
NZ524694A (en) * 2000-09-12 2005-05-27 Upjohn Co Pharmaceutical composition having modified carrier
CA2416563A1 (en) * 2000-09-12 2002-03-21 Pharmacia & Upjohn Company Pharmaceutical composition having specific water activity

Also Published As

Publication number Publication date
NO20051688L (no) 2005-08-02
KR20050085037A (ko) 2005-08-29
US7659061B2 (en) 2010-02-09
JP4656945B2 (ja) 2011-03-23
PL377740A1 (pl) 2006-02-20
CN1713923A (zh) 2005-12-28
MXPA05005319A (es) 2005-07-25
TWI267379B (en) 2006-12-01
WO2004045646A1 (en) 2004-06-03
AU2003276594B2 (en) 2009-01-08
TW200427466A (en) 2004-12-16
AR042193A1 (es) 2005-06-15
AU2003276594A1 (en) 2004-06-15
CA2502025C (en) 2013-07-02
JP2006514629A (ja) 2006-05-11
IL168183A (en) 2010-04-29
EP1569693A1 (en) 2005-09-07
BR0316310A (pt) 2005-09-27
RU2005115131A (ru) 2005-10-27
CA2502025A1 (en) 2004-06-03
US20040170650A1 (en) 2004-09-02
EP1569693B1 (en) 2016-12-28
NZ539923A (en) 2007-02-23
ZA200503040B (en) 2006-09-27
CN103272243A (zh) 2013-09-04
RU2401127C2 (ru) 2010-10-10

Similar Documents

Publication Publication Date Title
NO20051688D0 (no) Farmasoytiske blandinger som har en modifisert baerer
NO20052884D0 (no) Substituerte indolpyridinforbindelser som anti-infeksjonsmidler.
FR14C0032I2 (fr) Pyrazolopyridines a substitution carbamate
DK1414803T3 (da) Pyrazolylcarboxanilider som fungicider
NO20052952D0 (no) Farmasoytisk sammensetning som innbefatter mikropartikler
NO20044654L (no) Piperidinoylpiperidiner som 5-HTIF-agonister
DK2266650T3 (da) Lægemiddeldispenser
FIU20060387U0 (fi) Lantaaniyhdisteitä käsittävä farmaseuttinen koostumus
NO20052739D0 (no) CCR5-antagonister som medikamenter
DK1592457T3 (da) Folat-vinblastin-konjugat som lægemiddel
DK1638928T3 (da) N-alkynyl-2-(substituerede aryloxy)alkylthio-amidderivater som fungicider
IS7793A (is) Nýtt efnasamband
ATA2602002A (de) Verpackung
IS7794A (is) Nýtt efnasamband
DK1660090T3 (da) Quinazolin-analoger som receptor-tyrosinkinase-inhibitorer
DK1575948T3 (da) Pyridodiaziner som plantefungicider
DK1556377T3 (da) Cyclopropylthienylcarboxamider som fungicider
ITTO20030507A1 (it) Premistoppa a tenuta di fango.
DE60301419D1 (de) Verpackung
DK1569892T3 (da) Kalcilytiske forbindelser
IS7581A (is) Lyfjasamsetning
NO20053110D0 (no) 2-oksyamino-1-cyklopenten-1-nitriler som materialbeskyttelsesmidler.
NO20044164L (no) Farmasoytiske sammensetninger
ITMI20032550A1 (it) Mescole elastomeriche a base di nerofumo
PT102805B (pt) Embalagem colapsavel

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ZOETIS P&U LLC, US

FC2A Withdrawal, rejection or dismissal of laid open patent application